The clinical diagnosis of heparin-induced thrombocytopenia in patients receiving continuous renal replacement therapy

Journal of Thrombosis and Thrombolysis

Volumn 27, Issue 4, 2009, Pages 406-412

  Holmes, Chris E ^a   Huang, Joe C ^a   Cartelli, Carina ^a   Howard, Alan ^b   Rimmer, Jeffrey ^a   Cushman, Mary ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Continuous renal replacement therapy; Heparin; Heparin induced thrombocytopenia; Thrombocytopenia

Indexed keywords

HEPARIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; DISEASE COURSE; DRUG INDUCED DISEASE; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INTENSIVE CARE UNIT; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; TREATMENT RESPONSE; TREND STUDY;

ADULT; AGED; COHORT STUDIES; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 67349172721     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-008-0228-8     Document Type: Article

References (29)

1. Warkentin TE, Chong BH, Greinacher A (1998) A heparin-induced thrombocytopenia: Towards consensus. Thromb Haemost 79:1-7
2. Lo GK, Juhl D, Warkentin TE et al (2006) An evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. Thromb Haemost 4:759-765
3. Wester JP, Haas FJ, Biesma DH et al (2004) Thrombosis and hemorrhage in heparin-induced thrombocytopenia in seriously ill patients. Intensive Care Med 30:1927-1934
4. Napolitano LM, Warkentin TE, Almahameed A et al (2006) Heparin-induced thrombocytopenia in the critical care setting: Diagnosis and management. Crit Care Med 34:2898-2911
5. Stephan F, Hollande J, Richard O et al (2004) Thrombocytopenia in a surgical ICU. Chest 115:1363-1370
6. Vanderschueren S, De Weerdt A, Malbrain M et al (2000) Thrombocytopenia and prognosis in intensive care. Crit Care Med 28:1871-1876
7. Crowther MA, Cook DJ, Meade MO et al (2005) Thrombocytopenia in medical-surgical critically ill patients: Prevalence, incidence, and risk factors. J Crit Care 20:348-353
8. Warkentin TE, Sheppard JA, Horsewood P et al (2000) Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 96:1703-1708
9. Andreescu ACM, Possidente C, Hsieh M et al (2000) Evaluation of a pharmacy-based surveillance program for heparin-induced thrombocytopenia. Pharmacotherapy 20:974-980
10. Girolami B, Prandoni P, Stefani PM et al (2003) The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: A prospective cohort study. Blood 101:2955-2959
11. Verma AK, Levine M, Shalansky SJ et al (2003) Frequency of heparin-induced thrombocytopenia in critical care patients. Pharmacotherapy 23:745-753
12. Selleng K, Warkentin TE, Greinacher A (2007) Heparin-induced thrombocytopenia in intensive care patients. Crit Care Med 35:1165-1176
13. Mehta RL, Letteri JM (1999) Current status of renal replacement therapy for acute renal failure. A survey of US nephrologists. The National Kidney Foundation Council on Dialysis. Am J Nephrol 19:377-382
14. Silvester W, Bellomo R, Cole L (2001) Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med 29:1910-1915
15. Hyman A, Mendelssohn DC (2002) Current Canadian approaches to dialysis for acute renal failure in the ICU. Am J Nephrol 22:29-34
16. Ando M, Iwamoto Y, Suda A et al (2001) New insights into the thrombopoietic status of patients on dialysis through the evaluation of megakaryocytopoiesis in bone marrow and of endogenous thrombopoietin levels. Blood 97:915-921
17. Vinsonneau C, Camus C, Combes A et al (2006) Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: A multicentre randomised trial. Lancet 368:379-385
18. Yamamoto S, Koide M, Matsuo M et al (1996) Heparin-induced thrombocytopenia in hemodialysis patients. Am J Kidney Dis 28:82-85
19. de Sancho M, Lema MG, Amiral J et al (1996) Frequency of antibodies directed against heparin-platelet factor 4 in patients exposed to heparin through chronic hemodialysis. Thromb Haemost 75:695-696
20. Luzzatto G, Bertoli M, Cella G et al (1998) Platelet count, anti-heparin/ platelet factor 4 antibodies and tissue factor pathway inhibitor plasma antigen level in chronic dialysis. Thromb Res 89:115-122
21. Zachee P, Vermylen J, Boogaerts MA (1994) Hematologic aspects of end-stage renal failure. Ann Hematol 69:33-40
22. Descamps-Latscha B, Herbelin A, Nguyen AT et al (1994) Immune system dysregulation in uremia. Semin Nephrol 14:253-260
23. Kario K, Matsuo T, Yamada T et al (1994) Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis. Thromb Haemost 71:275-279
24. Warkentin TE, Kelton JG (2001) Temporal aspects of heparin-induced thrombocytopenia. New Eng J Med 344:1286-1292
25. Mulder J, Tan HK, Bellomo R et al (2003) Platelet loss across the hemofilter during continuous hemofiltration. Int J Artif Organs 26:906-912
26. Verbeelen D, Jochmans K, Herman AG et al (1991) Evaluation of platelets and hemostasis during hemodialysis with six different membranes. Nephron 59:567-572
27. Frank RD, Weber J, Dresbach H et al (2001) Role of contact system activation in hemodialyzer-induced thrombogenicity. Kidney Int 60:1972-1981
28. Amiral J, Peynauld-Debayle E, Wolf M et al (1996) Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low molecular weight heparin. Am J Hematol 52:90-95
29. Visentin GP, Malik M, Cyganiak KA et al (1996) Patients with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin: Platelet factor 4 complexes. J Lab Clin Med 128:376-383